IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.450
-0.090 (-5.84%)
Jun 5, 2026, 4:00 PM EDT - Market closed
IN8bio Market Cap
IN8bio has a market cap or net worth of $14.28 million as of June 5, 2026. Its market cap has increased by 24.84% in one year.
Market Cap
14.28M
Enterprise Value
-5.21M
1-Year Change
24.84%
Ranking
Category
Stock Price
$1.45
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $14.28M, a decrease of -92.39%. That is a compound annual growth rate of -41.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 14.28M | -37.49% |
| Dec 31, 2025 | 22.84M | 22.52% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
| Jul 30, 2021 | 187.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NewcelX | 16.96M |
| Moolec Science | 16.73M |
| Citius Pharmaceuticals | 16.18M |
| Vyome Holdings | 16.14M |
| Lexaria Bioscience | 15.76M |
| OSR Holdings | 14.60M |
| Cocrystal Pharma | 14.48M |
| CytoMed Therapeutics | 13.96M |